Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison on Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir in Kidney Transplant Recipients

NCT03631316 is registered in ClinicalTrials.gov with Luis Eduardo Morales Buenrostro as lead sponsor.

NCT NCT03631316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03631316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison on Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir in Kidney Transplant Recipients
Lead sponsor
Luis Eduardo Morales Buenrostro
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2018
Completion date
November 1, 2018
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infections, kidney transplantation, pharmacokinetics, therapeutic equivalency